In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Narrowing strength becomes a concern.
Biotech shares have gained from takeovers in that sector.
Here's a window into what institutional investors may be doing and how to profit from that.
Exact Sciences (EXAS) stock is gaining on Monday after the National Committee for Quality Assurance updated its guidelines on colorectal cancer screening tests.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.